Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba Extract for Cognitive Function in Acute Ischemic Stroke
NCT06140888Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of ginkgo biloba extract in ischemic stroke (2 arms). Primary endpoint: Montreal Cognitive Assessment at 180 days. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06140888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06140888.